| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director | Common Stock | 22,378 | $30,210 | $1.35 | 01 Oct 2025 | Direct |
| MIRA PHARMACEUTICALS, INC. | Director | Stock Options (right to buy) | 50,000 | 09 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MIRA | MIRA PHARMACEUTICALS, INC. | 01 Oct 2025 | 1 | +$30,210 | 4 | Director | 03 Oct 2025, 20:00 |
| MIRA | MIRA PHARMACEUTICALS, INC. | 09 Dec 2024 | 1 | $0 | 4 | Director | 10 Dec 2024, 17:15 |
| MIRA | MIRA PHARMACEUTICALS, INC. | 18 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:30 |
| MIRA | MIRA PHARMACEUTICALS, INC. | 25 Mar 2024 | 1 | $0 | 4 | Director | 27 Mar 2024, 17:53 |
| MIRA | MIRA PHARMACEUTICALS, INC. | 13 Mar 2024 | 0 | $0 | 3 | Director | 22 Mar 2024, 19:00 |